HIV incidence rates and risk factors for urban women in Zambia: Preparing for a microbicide clinical trial

Muzala Kapina, Cheri Reid, Karisse Roman, Elena Cyrus-Cameron, Antonia Kwiecien, Stephen M Weiss, Sten H. Vermund

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objectives: A preparedness study was conducted to evaluate the suitability of sites and populations following the same study procedures intended for a larger scale microbicide efficacy trial. In the process the study evaluated human immunodeficiency virus (HIV) incidence, prevalence, and risk profiles for HIV-acquisition among young women in urban Zambia. Methods: Women aged 16 to 49 years were screened for participation in the study that involved HIV/sexually transmitted infection testing and the assessment of sexual behavioral characteristics. Two hundred thirty-nine eligible women were enrolled and followed up for 12 months. Results: Baseline HIV prevalence at screening was 38.7% (95% CI: 34.2%-43.3%). The highest age-specific prevalence of HIV was 54.1% (95% CI: 46.3%-61.8%) seen in women aged 26 to 34 years. HIV incidence was 2.6% per 100 woman years. Pregnancy rates were high at 17.4 per 100 woman years (95% CI: 12.2-24.1). Conclusion: It was concluded that our general population sample, characterized by high HIV prevalence and ongoing incidence rates despite receiving regular risk reduction counseling and free condoms qualifies for future microbicide studies. A microbicide preparedness study conducted in Lusaka, Zambia found high HIV prevalence and appreciable HIV incidence in a population of women in an urban setting.

Original languageEnglish
Pages (from-to)129-133
Number of pages5
JournalSexually Transmitted Diseases
Volume36
Issue number3
DOIs
StatePublished - Mar 1 2009

Fingerprint

Zambia
Anti-Infective Agents
Clinical Trials
HIV
Incidence
Population
Condoms
Pregnancy Rate
Risk Reduction Behavior
Sexually Transmitted Diseases
Counseling

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases

Cite this

HIV incidence rates and risk factors for urban women in Zambia : Preparing for a microbicide clinical trial. / Kapina, Muzala; Reid, Cheri; Roman, Karisse; Cyrus-Cameron, Elena; Kwiecien, Antonia; Weiss, Stephen M; Vermund, Sten H.

In: Sexually Transmitted Diseases, Vol. 36, No. 3, 01.03.2009, p. 129-133.

Research output: Contribution to journalArticle

Kapina, Muzala ; Reid, Cheri ; Roman, Karisse ; Cyrus-Cameron, Elena ; Kwiecien, Antonia ; Weiss, Stephen M ; Vermund, Sten H. / HIV incidence rates and risk factors for urban women in Zambia : Preparing for a microbicide clinical trial. In: Sexually Transmitted Diseases. 2009 ; Vol. 36, No. 3. pp. 129-133.
@article{2c4221db8b524fcbbd676dbe4fa2f1b3,
title = "HIV incidence rates and risk factors for urban women in Zambia: Preparing for a microbicide clinical trial",
abstract = "Objectives: A preparedness study was conducted to evaluate the suitability of sites and populations following the same study procedures intended for a larger scale microbicide efficacy trial. In the process the study evaluated human immunodeficiency virus (HIV) incidence, prevalence, and risk profiles for HIV-acquisition among young women in urban Zambia. Methods: Women aged 16 to 49 years were screened for participation in the study that involved HIV/sexually transmitted infection testing and the assessment of sexual behavioral characteristics. Two hundred thirty-nine eligible women were enrolled and followed up for 12 months. Results: Baseline HIV prevalence at screening was 38.7{\%} (95{\%} CI: 34.2{\%}-43.3{\%}). The highest age-specific prevalence of HIV was 54.1{\%} (95{\%} CI: 46.3{\%}-61.8{\%}) seen in women aged 26 to 34 years. HIV incidence was 2.6{\%} per 100 woman years. Pregnancy rates were high at 17.4 per 100 woman years (95{\%} CI: 12.2-24.1). Conclusion: It was concluded that our general population sample, characterized by high HIV prevalence and ongoing incidence rates despite receiving regular risk reduction counseling and free condoms qualifies for future microbicide studies. A microbicide preparedness study conducted in Lusaka, Zambia found high HIV prevalence and appreciable HIV incidence in a population of women in an urban setting.",
author = "Muzala Kapina and Cheri Reid and Karisse Roman and Elena Cyrus-Cameron and Antonia Kwiecien and Weiss, {Stephen M} and Vermund, {Sten H.}",
year = "2009",
month = "3",
day = "1",
doi = "10.1097/OLQ.0b013e318190191d",
language = "English",
volume = "36",
pages = "129--133",
journal = "Sexually Transmitted Diseases",
issn = "0148-5717",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - HIV incidence rates and risk factors for urban women in Zambia

T2 - Preparing for a microbicide clinical trial

AU - Kapina, Muzala

AU - Reid, Cheri

AU - Roman, Karisse

AU - Cyrus-Cameron, Elena

AU - Kwiecien, Antonia

AU - Weiss, Stephen M

AU - Vermund, Sten H.

PY - 2009/3/1

Y1 - 2009/3/1

N2 - Objectives: A preparedness study was conducted to evaluate the suitability of sites and populations following the same study procedures intended for a larger scale microbicide efficacy trial. In the process the study evaluated human immunodeficiency virus (HIV) incidence, prevalence, and risk profiles for HIV-acquisition among young women in urban Zambia. Methods: Women aged 16 to 49 years were screened for participation in the study that involved HIV/sexually transmitted infection testing and the assessment of sexual behavioral characteristics. Two hundred thirty-nine eligible women were enrolled and followed up for 12 months. Results: Baseline HIV prevalence at screening was 38.7% (95% CI: 34.2%-43.3%). The highest age-specific prevalence of HIV was 54.1% (95% CI: 46.3%-61.8%) seen in women aged 26 to 34 years. HIV incidence was 2.6% per 100 woman years. Pregnancy rates were high at 17.4 per 100 woman years (95% CI: 12.2-24.1). Conclusion: It was concluded that our general population sample, characterized by high HIV prevalence and ongoing incidence rates despite receiving regular risk reduction counseling and free condoms qualifies for future microbicide studies. A microbicide preparedness study conducted in Lusaka, Zambia found high HIV prevalence and appreciable HIV incidence in a population of women in an urban setting.

AB - Objectives: A preparedness study was conducted to evaluate the suitability of sites and populations following the same study procedures intended for a larger scale microbicide efficacy trial. In the process the study evaluated human immunodeficiency virus (HIV) incidence, prevalence, and risk profiles for HIV-acquisition among young women in urban Zambia. Methods: Women aged 16 to 49 years were screened for participation in the study that involved HIV/sexually transmitted infection testing and the assessment of sexual behavioral characteristics. Two hundred thirty-nine eligible women were enrolled and followed up for 12 months. Results: Baseline HIV prevalence at screening was 38.7% (95% CI: 34.2%-43.3%). The highest age-specific prevalence of HIV was 54.1% (95% CI: 46.3%-61.8%) seen in women aged 26 to 34 years. HIV incidence was 2.6% per 100 woman years. Pregnancy rates were high at 17.4 per 100 woman years (95% CI: 12.2-24.1). Conclusion: It was concluded that our general population sample, characterized by high HIV prevalence and ongoing incidence rates despite receiving regular risk reduction counseling and free condoms qualifies for future microbicide studies. A microbicide preparedness study conducted in Lusaka, Zambia found high HIV prevalence and appreciable HIV incidence in a population of women in an urban setting.

UR - http://www.scopus.com/inward/record.url?scp=62849111059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62849111059&partnerID=8YFLogxK

U2 - 10.1097/OLQ.0b013e318190191d

DO - 10.1097/OLQ.0b013e318190191d

M3 - Article

C2 - 19174729

AN - SCOPUS:62849111059

VL - 36

SP - 129

EP - 133

JO - Sexually Transmitted Diseases

JF - Sexually Transmitted Diseases

SN - 0148-5717

IS - 3

ER -